Colloquially name | Scientific name: Pangolin Nextstrain | Defined by | Important mutations | Countries reported (first detected) | Increased transmissibility | Increased COVID-19 mortality or severity | Effect on vaccines |
---|---|---|---|---|---|---|---|
UK variant | B.1.1.7 20I/501Y.V1 VUI-202012/01 | 17 SNPs | -N501Y -69/70 deletion -P681H -D619G | 75 (34) (United Kingdom) | Oxford/AstraZeneca still effective [269] | ||
South African variant | B.1.351 20H/501Y.V2 | 9 SNPs | -N501Y -K417N -E484K -D619G | 32 (34) (South Africa) | Yes (~ 50%) | Possibly [270] | |
Brazil variant | P.1 B.1.1.28 20Â J/501Y.V3 | 19 SNPs | -N501Y -K417T -E484K -D619G | 12 (34) (Brazil) | Yes [35] | N/A | N/A |
New York | B.1.525–B.1.526 20C | 13 SNPs | -D614G -E484K -Q677H -F888L | 30 (Multiple) | yes | N/A | Reduction in neutralization by monoclonal antibodies |
California | B.1.427–B.1.429 20C/S:452R | 10 SNPS | -L452R -D624G -N501Y | N/A | Yes (~ 20%) | N/A | Reduction in neutralization by monoclonal antibodies |